Many times I have asked myself this question (when to acknowledge it’s over). I have nearly gotten out entirely a couple of times.
Many times it has seemed that they would have to make a definitive announcement or else run out of funds, but every time so far they managed to raise more diluting equity, refinance loans, borrow more, or all of the above.
Perhaps when Linda Liau started distancing herself more clearly, that should have been a red flag, but Dr. Ashkan seemed to step into the breach.
It does appear that they are puttering forward. The regulatory process is daunting, so maybe possibly it makes sense that they are taking so effing forever.
There are undeniably several long-tail survivors, which should indeed count for a lot in this disease, and I very much hope the U.S. regulators understand that. I say it as the wife of a former Grade III patient.
Ultimately, as much as I’d like it, I’m not here to get rich quick. I want to be a part of the solution to brain cancer, so I am sticking around a little longer. I’ve certainly learned a lot along the way.